Nocion Therapeutics is a clinical-stage biopharmaceutical company developing novel charged sodium channel blockers “nocions” for the treatment of refractory chronic cough.
Arkin Entry Stage
Clinical
Status
Active
Location
Boston, MA
Let’s get in touch!
